Old Dominion Capital Management’s Biogen BIIB Stock Holding History

Old Dominion Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$950K	Sell	3,357 -26	-0.8%	-$8.52K	0.2%	92
2021 Q2	$1.17M	Sell	3,383 -2,370	-41%	-$718K	0.25%	84
2021 Q1	$1.61M	Sell	5,753 -1,685	-23%	-$454K	0.37%	70
2020 Q4	$1.82M	Sell	7,438 -2,576	-26%	-$665K	0.45%	55
2020 Q3	$2.84M	Sell	10,014 -285	-3%	-$79.5K	0.8%	40
2020 Q2	$2.75M	Hold	10,299	–	–	0.85%	37
2020 Q1	$3.26M	Sell	10,299 -2,753	-21%	-$835K	1.34%	26
2019 Q4	$3.87M	Sell	13,052 -563	-4%	-$156K	1.26%	26
2019 Q3	$3.17M	Sell	13,615 -1,040	-7%	-$242K	1.06%	29
2019 Q2	$3.43M	Sell	14,655 -305	-2%	-$70.4K	1.19%	27
2019 Q1	$3.46M	Sell	14,960 -6,061	-29%	-$1.91M	1.18%	26
2018 Q4	$6.33M	Hold	21,021	–	–	2.29%	11
2018 Q3	$7.43M	Buy	+21,021	New	+$7.24M	2.26%	11

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Old Dominion Capital Management's BIIB Position: Q3 2021 in Review

Old Dominion Capital Management reduced its Biogen (BIIB) stake by 0.77% in Q3 2021, selling an estimated $8.52K and leaving 3,357 shares worth $950K. The position accounts for 0.2% of the portfolio, ranked #92.

Old Dominion Capital Management first reported a position in BIIB in Q3 2018 and has held it in 13 quarters since. The position peaked at $7.43M in Q3 2018. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

Old Dominion Capital Management held 3,357 shares of Biogen worth $950K as of Q3 2021.
Old Dominion Capital Management sold 26 Biogen shares in Q3 2021, an estimated $8.52K.
Biogen made up 0.2% of Old Dominion Capital Management's portfolio in Q3 2021, its #92 holding.
Old Dominion Capital Management first reported a position in Biogen in Q3 2018 and has held it in 13 quarters since.
Old Dominion Capital Management's Biogen position peaked at $7.43M in Q3 2018.
1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.